click below
click below
Normal Size Small Size show me how
Antidiabetic Meds
Med Knowledge II
| Term | Definition |
|---|---|
| what is the brand name of metformin | glucophage |
| what is the therapeutic class of metformin | antidiabetic |
| what is the pharmacologic class of metformin | biguanide |
| what is the brand name of glimepiride | amaryl |
| what is the therapeutic class of glimepiride | antidiabetic |
| what is the pharmacologic class of glimepiride | sulfonylurea |
| what is the brand name of glipizide | glucotrol |
| what is the therapeutic class of glipizide | antidiabetic |
| what is the pharmacologic class of glipizide | sulfonylurea |
| what is the brand name of pioglitazone | actos |
| what is the therapeutic class of pioglitazone | antidiabetic |
| what is the pharmacologic class of pioglitazone | TZD |
| what is the brand name of repaglinide | prandin |
| what is the therapeutic class of repaglinide | antidiabetic |
| what is the pharmacologic class of repaglinide | meglitinide |
| what is the brand name of canaglifozin | invokana |
| what is the therapeutic class of canaglifozin | antidiabetic |
| what is the pharmacologic class of canaglifozin | SGLT-2 Inhibitor |
| what is the brand name of dapaglifozin | farxiga |
| what is the therapeutic class of dapaglifozin | antidiabetic |
| what is the pharmacologic class of dapaglifozin | SGLT-2 Inhibitor |
| what is the brand name empaglifozin | jardiance |
| what is the therapeutic class of empaglifozin | antidiabetic |
| what is the pharmacologic class of empaglifozin | SLGT-2 Inhibitor |
| what is the brand name of dulaglutide | trulicity |
| what is the therapeutic class of dulaglutide | antidiabetic |
| what is the pharmacologic class of dulaglutide | GLP-1 Receptor Agonist |
| what is the brand name of exenatide | byetta/bydureon |
| what is the therapeutic class of exenatide | antidiabetic |
| what is the pharmacologic class of exenatide | GLP-1 Receptor Agonist |
| what is the brand name of liraglutide | victoza |
| what is the therapeutic class of liraglutide | antidiabetic |
| what is the pharmacologic class of liraglutide | GLP-1 Receptor Agonist |
| what is the brand name of semaglutide | ozempic |
| what is the therapeutic class of semaglutide | antidiabetic |
| what is the pharmacologic class of semaglutide | GLP-1 receptor agonist |
| what is the brand name of tirzepatide | mounjaro |
| what is the therapeutic class of tirzepatide | antidiabetic |
| what is the pharmacologic class of tirzepatide | GLP-1RA/GIP Agonist |
| what is the brand name of saxagliptin | onglyza |
| what is the therapeutic class of saxagliptin | antidiabetic |
| what is the pharmacologic class of saxagliptin | DPP-4 Inhibitor |
| what is the brand name of sitagliptin | januvia |
| what is the therapeutic class of sitagliptin | antidiabetic |
| what is the pharmacologic class of sitagliptin | DPP-4 Inhibitor |
| what is the brand name of linagliptin | tradjenta |
| what is the therapeutic class of linagliptin | antidiabetic |
| what is the pharmacologic class of linagliptin | DPP-4 Inhibitor |
| what is the brand name of semaglutide (weight loss) | wegovy |
| what is the therapeutic class of semaglutide | weight loss |
| what is the pharmacologic class of semaglutide (weight loss) | GLP-1 Agonist |
| what is the brand name of tirzepatide (weight loss) | zepbound |
| what is the therapeutic class of tirzepatide | weight loss |
| what is the pharmacologic class of tirzepatide (weight loss) | GLP-1 Agonist |
| what is the MOA of metformin | decreased glucose production and improved glucose uptake into cells |
| what is the MOA of glimepiride | stimulate insulin release from pancreatic beta cells |
| what is the MOA of glipizide | stimulate insulin release from pancreatic beta cells |
| what is the MOA of pioglitazone | increases insulin sensitivity in muscle, fat, and liver cells |
| what is the MOA of repaglinide | work on pancreatic beta cells to stimulate insulin release |
| what is the MOA of canaglifozin | prevents glucose reabsorption in the kidneys to lower blood glucose levels |
| what is the MOA of dapaglifozin | prevents glucose reabsorption in the kidneys to lower blood glucose levels |
| what is the MOA of empaglifozin | prevents glucose reabsorption in the kidneys to lower blood glucose levels |
| what is the MOA of dulaglutide | exogenous GLP-1 hormone that stimulates insulin release |
| what is the MOA of exenatide | exogenous GLP-1 hormone that stimulates insulin release |
| what is the MOA of liraglutide | exogenous GLP-1 hormone that stimulates insulin release |
| what is the MOA of semaglutide | exogenous GLP-1 hormone that stimulates insulin release |
| what is the MOA of tirzepatide | exogenous GLP-1 hormone that stimulates insulin release |
| what is the MOA of saxagliptin | inhibits breakdown of GLP-1 |
| what is the MOA of sitagliptin | inhibits breakdown of GLP-1 |
| what is the MOA of linagliptin | inhibits breakdown of GLP-1 |
| what is the major characteristic of metformin | diarrhea |
| what is the major characteristic of glimepiride | hypoglycemia risk |
| what is the major characteristic of glipizide | hypoglycemia risk |
| what is the major characteristic of pioglitazone | weight gain and edema |
| what is the major characteristic of repaglinide | hypoglycemia |
| what is the major characteristic of canaglifozin | increased risk of urogenital infections |
| what is the major characteristic of dapaglifozin | increased risk of urogenital infections |
| what is the major characteristic of empaglifozin | increased risk of urogenital infections |
| what is the major characteristic of dulaglutide | GI upset |
| what is the major characteristic of exenatide | GI upset |
| what is the major characteristic of liraglutide | GI upset |
| what is the major characteristic of semaglutide | GI upset |
| what is the major characteristic of tirzepatide | GI upset |
| what is the major characteristic of saxagliptin | can't use with GLP-1 |
| what is the major characteristic of sitagliptin | can't use with GLP-1 |
| what is the major characteristic of linagliptin | can't use with GLP-1 |